Supply Chain
The U.S. Department of Justice announced late last week that GE Healthcare has paid more than $30 million to the government to settle False Claims Act allegations.
As drug shortages become more frequent and severe, providers are feeling the financial impact of the higher-priced alternatives and the personnel hours required to deal with the escalating problem.
Even though the Centers for Medicare & Medicaid Services has taken steps to curtail fraud and abuse from Medicare suppliers of durable medical equipment, prosthetics, orthotics and supplies (DMEPOS), it needs to do more says a recently released report from the Office of Inspector General.
Healthcare real estate will continue to be a strong investment category in 2012 concludes an analysis by Jones Lang LaSalle, a financial and professional services firm specializing in real estate.
Pharmaceutical companies outsourced $36.6 billion in global research and development expenses to contract drug developers in 2011, up 6.6 percent from 2009, according to healthcare research firm Kalorama Information.
The proportion of Americans reporting problems affording prescription drugs remained level between 2007 and 2010, with more than one in eight going without a prescribed drug in 2010, according to a national study released today by the Center for Studying Health System Change. Despite the flat numbers, the news isn't necessarily good.
Fujifilm Holdings Corporation announced Wednesday that it has entered into a definitive agreement to acquire ultrasound technology firm SonoSite, Inc. for approximately $995 million.
Cardinal Health, a Dublin, Ohio-based, Fortune 19, healthcare services company has been ranked in the number one spot in Gartner's third annual Healthcare Supply Chain Top 25, replacing med-surg supplier Owens & Minor, which dropped to fifth place.
Between 2010 and 2020 the overall market for chronic pain therapies will remain stable at approximately $20 billion, with treatments for back pain and arthritis predicted to be the most lucrative, according to findings from healthcare research firm Decision Resources.
The Centers for Medicare & Medicaid Services (CMS) announced Wednesday operational details for the next stage in its competitive bidding program despite ongoing opposition from patient advocacy groups, economists and 145 members of Congress.